Fresenius SE & Co. (OTCMKTS:FSNUY) Stock Price Down 2.8% - Here's Why

Fresenius SE & Co. (OTCMKTS:FSNUY - Get Free Report)'s share price dropped 2.8% during mid-day trading on Tuesday . The company traded as low as $12.29 and last traded at $12.36. Approximately 23,832 shares traded hands during mid-day trading, a decline of 38% from the average daily volume of 38,500 shares. The stock had previously closed at $12.72.

Analyst Upgrades and Downgrades

Separately, Morgan Stanley reaffirmed an "overweight" rating on shares of Fresenius SE & Co. in a research note on Thursday, May 15th.

Fresenius SE & Co. Stock Up 0.2%

The business has a fifty day moving average of $12.05 and a 200 day moving average of $10.55. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 1.43.

Fresenius SE & Co. (OTCMKTS:FSNUY - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.23 EPS for the quarter, topping the consensus estimate of $0.22 by $0.01. Fresenius SE & Co. had a net margin of 1.92% and a return on equity of 9.06%. The business had revenue of $5.92 billion during the quarter, compared to analyst estimates of $5.41 billion. On average, equities analysts predict that Fresenius SE & Co. will post 0.79 earnings per share for the current fiscal year.

Fresenius SE & Co. Increases Dividend

The business also recently declared a dividend, which was paid on Wednesday, June 4th. Investors of record on Wednesday, May 28th were given a dividend of $0.1827 per share. The ex-dividend date was Tuesday, May 27th. This represents a dividend yield of 1.48%. This is a boost from Fresenius SE & Co.'s previous dividend of $0.17. Fresenius SE & Co.'s payout ratio is currently 100.00%.

Fresenius SE & Co. Company Profile

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.